类风湿性关节炎的全球市场 - 产业分析，规模，占有率，成长，趋势，2022年～2028年的预测

本报告提供全球类风湿性关节炎市场相关调查，提供市场概要，以及不同治疗，各流通管道，各地区的趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 序文

第2章 摘要整理

第3章 类风湿性关节炎-产业分析

• 简介-市场动态
• 市场促进因素
• 市场阻碍因素
• 机会
• 产业趋势
• 波特的五力分析
• 市场魅力分析

第4章 价值链分析

第5章 COVID-19疫情的影响分析

第6章 全球类风湿性关节炎市场分析，不同治疗

• 不同治疗概要
• 履历资料与预测资料
• 不同治疗分析
• 对症疗法的销售额实际成果及预测销售额，各地区
• 中间皮质类固醇治疗的销售额实际成果及预测销售额，各地区
• 缓解疾病性抗风湿药(DMARD)疗法的销售额实际成果及预测销售额，各地区

第7章 全球类风湿性关节炎市场分析，各流通管道

• 各流通管道概要
• 履历资料与预测资料
• 各流通管道分析
• 院内药局的销售额实际成果及预测销售额，各地区
• 零售药局的销售额实际成果及预测销售额，各地区
• 药妆店的销售额实际成果及预测销售额，各地区

第8章 全球类风湿性关节炎市场分析，各地区

• 各地区的预测
• 简介
• 北美的销售额分析
• 欧洲的销售额分析
• 亚太地区的销售额分析
• 南美的销售额分析
• 中东·非洲的销售额分析

第9章 类风湿性关节炎企业的竞争情形

• 类风湿性关节炎市场上竞争
• 伙伴关係/合作/契约
• 合併和收购
• 新产品的销售
• 其他的开发

第10章 企业简介

• 主要企业的市场占有率分析
• 市场集中度
• AbbVie Inc.
• Amgen Inc.
• Bristol-Myers Squibb Company
• Eli Lilly &Company
• F. Hoffman-La Roche AG
• Johnson &Johnson
• Pfizer Inc.
• Sanofi SA
• Sobi Inc.
• UCB SA
• 其他

Value Market Research deeply researched the Global Rheumatoid Arthritis Market to foresee a significant growth in the industry over the upcoming years. The global rheumatoid arthritis market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global rheumatoid arthritis market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this rheumatoid arthritis market.

The next sections of the rheumatoid arthritis market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America - United States, Canada, and Mexico

Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC

Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below-

By Treatment

Symptomatic Treatment

Intermediate Corticosteroid Treatment

Disease Modifying Anti-Rheumatic Drug {DMARD} Therapies

Conventional DMARD

Biologic DMARD

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Drug Stores

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . RHEUMATOID ARTHRITIS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Treatment
  • 3.7.2 Market Attractiveness Analysis By Distribution Channel
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

• 5.1. Impact Analysis of Covid-19 Outbreak
  • 5.1.1. Direct Impact on Production
  • 5.1.2. Supply Chain and Market Disruption
  • 5.1.3. Financial Impact on Firms and Financial Markets
• 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
• 5.3. Market: Pre V/S Post COVID-19
• 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
• 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL RHEUMATOID ARTHRITIS MARKET ANALYSIS BY TREATMENT

• 6.1 Overview by Treatment
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Treatment
• 6.4 Symptomatic Treatment Historic and Forecast Sales by Regions
• 6.6 Intermediate Corticosteroid Treatment Historic and Forecast Sales by Regions
• 6.5 Disease Modifying Anti-Rheumatic Drug {DMARD} Therapies Historic and Forecast Sales by Regions

7 . GLOBAL RHEUMATOID ARTHRITIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

• 7.1 Overview by Distribution Channel
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Distribution Channel
• 7.4 Hospital Pharmacies Historic and Forecast Sales by Regions
• 7.5 Retail Pharmacies Historic and Forecast Sales by Regions
• 7.6 Drug Stores Historic and Forecast Sales by Regions

8 . GLOBAL RHEUMATOID ARTHRITIS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE RHEUMATOID ARTHRITIS COMPANIES

• 9.1. Rheumatoid Arthritis Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF RHEUMATOID ARTHRITIS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. AbbVie Inc.
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Amgen Inc.
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Bristol-Myers Squibb Company
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Eli Lilly & Company
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. F. Hoffman-La Roche AG
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Johnson & Johnson
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Pfizer Inc.
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. Sanofi SA
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. Sobi Inc.
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. UCB S.A.
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments
• 10.13. Others.
  • 10.13.1. Company Overview
  • 10.13.2. Company Revenue
  • 10.13.3. Products
  • 10.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• COVID-19 Impact Analysis by Production, Import, Export and Demand
• Pre V/S Post COVID-19
• Estimated Impact Of The Coronavirus (Covid-19) Epidemic
• COVID-19: Micro and Macro Factor Analysis
• Analysis by Treatment (USD MN)
• Symptomatic Treatment Market Sales by Geography (USD MN)
• Intermediate Corticosteroid Treatment Market Sales by Geography (USD MN)
• Disease Modifying Anti-Rheumatic Drug {DMARD} Therapies Market Sales by Geography (USD MN)
• Analysis Market by Distribution Channel (USD MN)
• Hospital Pharmacies Market Sales by Geography (USD MN)
• Retail Pharmacies Market Sales by Geography (USD MN)
• Drug Stores Market Sales by Geography (USD MN)
• Global Rheumatoid Arthritis Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Rheumatoid Arthritis Report
• Market Research Process
• Market Research Methodology
• Global Rheumatoid Arthritis Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Treatment
• Market Attractiveness Analysis by Distribution Channel
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Treatment (USD MN)
• Symptomatic Treatment Market Sales by Geography (USD MN)
• Intermediate Corticosteroid Treatment Market Sales by Geography (USD MN)
• Disease Modifying Anti-Rheumatic Drug {DMARD} Therapies Market Sales by Geography (USD MN)
• Global Market Analysis by Distribution Channel (USD MN)
• Hospital Pharmacies Market Sales by Geography (USD MN)
• Retail Pharmacies Market Sales by Geography (USD MN)
• Drug Stores Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.